Prot# PULSE-PAH-004: A Phase 3, Placebo Controlled, Double-blind, Randomized, Clinical Study to Determine Efficacy, Safety and Tolerability of Pulsed, Inhaled Nitric Oxide (iNO) versus Placebo in Symptomatic Subjects with Pulmonary Arterial Hypertension (

Project: Research project

Project Details

Effective start/end date11/2/1611/2/19


  • Worldwide Clinical Trials, Inc. (PULSE-PAH-004 // PULSE-PAH-004)
  • Bellerophon Pulse Technologies LLC (PULSE-PAH-004 // PULSE-PAH-004)